(Hypertension. 1999;33:856-861.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pathology, University of Iowa College of Medicine and Cardiovascular Center, Iowa City, Iowa.
Correspondence to Gary L. Baumbach, MD, Department of Pathology, 5232-A RCP, 100 Medical Laboratories, University of Iowa College of Medicine, Iowa City, IA 52242. E-mail g-baumbach{at}uiowa.edu
AbstractWe examined the effects of an angiotensin-converting enzyme inhibitor, perindopril, and a ß-blocker, propranolol, on cerebral arterioles in stroke-prone spontaneously hypertensive rats (SHRSP). The structure and mechanics of cerebral arterioles were examined in untreated Wistar-Kyoto rats (WKY) and SHRSP that were untreated or treated for 3 months with a high (2 mg/kg per day) or a low (0.3 mg/kg per day) dose of perindopril or propranolol (250 mg/kg per day) alone or in combination with the low dose of perindopril. We measured pressure, external diameter, and cross-sectional area of the vessel wall (CSA) in maximally dilated (with EDTA) cerebral arterioles. Treatment of SHRSP with the high dose of perindopril or the combination of propranolol and the low dose of perindopril normalized cerebral arteriolar mean pressure (50±1 [mean±SEM] and 43±2 mm Hg vs 50±1 mm Hg in WKY and 94±3 mm Hg in untreated SHRSP; P<0.05), pulse pressure (15±1 and 16±1 mm Hg vs 13±1 mm Hg in WKY and 35±1 mm Hg in untreated SHRSP; P<0.05), and CSA (1103±53 and 1099±51 µm2, respectively, vs 1057±49 µm2 in WKY and 1281±62 µm2 in untreated SHRSP; P<0.05). In contrast, treatment of SHRSP with the low dose of perindopril or propranolol alone did not normalize arteriolar pulse pressure (24±1 and 21±1 mm Hg) and failed to prevent increases in CSA (1282±77 and 1267±94 µm2). Treatment with either dose of perindopril or the combination of propranolol and perindopril significantly increased external diameter in cerebral arterioles of SHRSP (99±3, 103±2, and 98±3 µm vs 87±2 µm in untreated SHRSP; P<0.05), whereas propranolol alone did not (94±3 µm; P>0.05). These findings suggest that effects of angiotensin-converting enzyme inhibitors on cerebral arteriolar hypertrophy in SHRSP may depend primarily on their effects on arterial pressure, particularly pulse pressure, whereas their effects on cerebral arteriolar remodeling (defined as a reduction in external diameter) may be pressure independent.
Key Words: hypertension, chronic vascular remodeling angiotensin hypertrophy, vascular
This article has been cited by other articles:
![]() |
L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger The Plastic Nature of the Vascular Wall: A Continuum of Remodeling Events Contributing to Control of Arteriolar Diameter and Structure Physiology, February 1, 2009; 24(1): 45 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Jennings, M. F. Muldoon, J. Price, I. C. Christie, and C. C. Meltzer Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment Hypertension, July 1, 2008; 52(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cipolla, J. Smith, N. Bishop, L. V. Bullinger, and J. A. Godfrey Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries Hypertension, April 1, 2008; 51(4): 1052 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zuliani, A. Cherubini, S. Volpato, A. R. Atti, A. Ble, C. Vavalle, F. Di Todaro, C. Benedetti, C. Ruggiero, U. Senin, et al. Treatment With Angiotensin-Converting Enzyme Inhibitors Is Associated With a Reduction in Short-Term Mortality in Older Patients With Acute Ischemic Stroke J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 463 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Chillon and G. L. Baumbach Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Cerebral Arterioles in Hypertensive Rats Hypertension, May 1, 2004; 43(5): 1092 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Cerebral Arteriolar Structure in Mice Overexpressing Human Renin and Angiotensinogen Hypertension, January 1, 2003; 41(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.I. Levy, G. Ambrosio, A.R. Pries, and H.A.J. Struijker-Boudier Microcirculation in Hypertension: A New Target for Treatment? Circulation, August 1, 2001; 104(6): 735 - 740. [Full Text] [PDF] |
||||
![]() |
J.-M. Chillon and G. L. Baumbach Effects of an Angiotensin-Converting Enzyme Inhibitor and a {beta}-Blocker on Cerebral Arteriolar Dilatation in Hypertensive Rats Hypertension, June 1, 2001; 37(6): 1388 - 1393. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |